CareMax, Inc. Warrant - CMAXW STOCK NEWS

CareMax, Inc. (NASDAQ: CMAX; CMAXW) has appointed Mr. Jose R. Rodriguez as the new Chair of its board of directors, succeeding Mr. Richard A. Barasch. Rodriguez has been on the board since June 2021 and brings extensive experience in corporate governance and management. Barasch will remain an advisor. CEO Carlos de Solo expressed confidence in the leadership transition, emphasizing CareMax's growth to over 32,000 Medicare Advantage members by the end of 2021. The company focuses on value-based care and chronic disease management for seniors, aiming to improve outcomes and reduce costs.

CareMax, Inc. (NASDAQ: CMAX; CMAXW), a leader in technology-enabled value-based care for seniors, announced that its CEO, Carlos de Solo, will present at the 40th Annual J.P. Morgan Healthcare Conference on January 13, 2022, at 12:00 pm EST. A live webcast and replay will be accessible on their investor relations website.

CareMax focuses on chronic disease management and operates medical centers across the US, providing comprehensive healthcare and social services.

CareMax, Inc. (NASDAQ: CMAX; CMAXW), a leading provider of value-based care for seniors, announced participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 29 to December 2, 2021. Key executives including Carlos de Solo, Kevin Wirges, and Ben Quirk will represent the company. A pre-recorded fireside chat is accessible on CareMax’s investor relations website.

CareMax specializes in technology-enabled care platforms, focusing on chronic disease management and healthcare services across the United States.

CareMax, Inc. (NASDAQ: CMAX; CMAXW) reported a remarkable financial performance for Q3 2021, with GAAP total revenue of $104.6 million, reflecting a 330% year-over-year increase. Year-to-date revenue reached $177.5 million, up 136% year-over-year. Medicare Advantage membership surged by over 340% to 26,500. However, the company reported a net loss of $2.9 million for the quarter. CareMax reaffirmed its 2021 guidance, aiming for $490 million to $525 million in revenue and $30 million to $40 million in Adjusted EBITDA. Key strategic moves included the acquisition of DNF Medical Centers and collaborations to expand medical centers.

CareMax, Inc. (NASDAQ: CMAX; CMAXW), a provider of value-based care for seniors, announced that its leadership team will present at the Credit Suisse 30th Annual Healthcare Conference on November 10, 2021, at 2:40 pm ET. The presentation will be held virtually, and interested parties can access a live webcast and a replay on CareMax’s investor relations website at ir.caremax.com. CareMax operates medical centers offering a comprehensive range of healthcare services and utilizes a proprietary technology platform for chronic disease management.

CareMax, Inc. (NASDAQ: CMAX; CMAXW) plans to release its third-quarter financial results for the period ended September 30, 2021, on November 15, 2021, before the market opens.

Management will conduct a conference call at 8:30 am ET on the same day to discuss the results and business activities. Interested participants can join the call via domestic and international numbers provided in the release.

CareMax is known for its technology-enabled care and chronic disease management services aimed at seniors, operating medical centers across the United States.

CareMax, Inc. (NASDAQ: CMAX; CMAXW) has appointed Beatriz Assapimonwait as an independent board member. With 38 years of Medicare managed care experience, including leadership roles at Humana and Family Physicians of Winter Park, Assapimonwait aims to enhance the company’s value-based care for seniors. CEO Carlos de Solo emphasized her extensive managed care expertise and successful healthcare operations background. This strategic addition could bolster CareMax's mission to optimize patient outcomes and reduce costs.

CareMax, Inc. (NASDAQ: CMAX; CMAXW) announced the appointment of Dr. Vincent Omachonu to its board of directors. Dr. Omachonu brings extensive expertise in managed care and process improvement, aiming to enhance CareMax’s value-based care model. He is a professor at the University of Miami, with a strong background in healthcare quality improvement, and has been pivotal in adopting methodologies that enhance patient care. CEO Carlos de Solo expressed confidence in leveraging Dr. Omachonu's experience to expand CareMax's reach across the nation.